Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Ever Forward Radio with Chase Chewning

EFR 556: How to Become Someone You Are Proud Of and Go From Being an Unconscious Consumer to Conscious Creator with Matthew Paetz

08 Dec 2021

Description

Matthew Paetz returns on Ever Forward Radio to share how he has been navigating the seemingly endless period of uncertainty brought about by the pandemic—particularly around how he has been striving to shift from being what he calls an "unconscious consumer" to being a "conscious creator". "I'm creating a life I've never had by doing things I've never done," says Matthew, adding that his focus has been on building on himself over his achievements. One of the major ways he has been doing this over the past 18 months is by immersing himself in the world of psychedelic-assisted psychotherapy as a modality for addressing trauma. Matthew defines these guided sessions as "medicines for the soul"—contrasting it with alcohol which he calls "medicine for the ego". He then breaks down the development of our ego and how these sessions allow you to detach from that ego and see your life from a completely different perspective. "These medicines, in a guided session, would be the greatest gift I could give the entire world," says Matthew. He believes that, should the public embrace this gift, Western medicine as it pertains to mental health would be "eradicated" in a matter of months.   Follow Matthew @matthewpaetz Follow Chase @chase_chewning   Episode resources: Matthew first appeared in episode 383 Save 15% on Cured Nutrition with code EVERFORWARD at www.CuredNutrition.com  Learn more and watch the full video at https://chasechewning.com/podcasts/episode/556 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.